Last updated: 2026-10-13 09:22:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Beyond Air, Inc. (XAIR) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2.28, with a market capitalisation of $2.21M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.20 to $55.00. This page covers its latest market performance, valuation, price trends and company information.
$2.21M | |
$2.35 | |
$6,564.00 | |
$2.20 | |
$2.31 | |
1.00 | |
225.08K | |
-- | |
$55.00 | |
$2.20 | |
-- | |
-- |
Beyond Air, Inc. (XAIR) is trading at $2.28 in pre-market trading as of 2026-10-13 08:10:00, down 1.43% ($0.03) from the previous close of $2.31
Pre-market trading shows how investors are pricing XAIR before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Beyond Air, Inc. (XAIR) moved from $2.82 to $2.28, representing a decline of 19.26% ($0.54).
The stock traded between $2.20 and $2.99 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 47.09 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.1%
XAIR is currently trading at $2.28, placing it 0.1% of the way from its 52-week low of $2.20 to its 52-week high of $55.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 54 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Beyond Air, Inc. (XAIR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.